急诊疑似急性冠脉综合征离院后门诊心脏负荷试验的评估
该回顾性分析纳入2015年6月至2017年6月南加州13家社区急诊中因胸痛就诊、检测肌钙蛋白并离院时开具门诊心脏负荷试验处方的7,988例成人患者。结果显示31.3%在3天内完成负荷试验,58.7%在4至30天完成,10.0%未完成。30天主要不良心脏事件发生率低(死亡0.0%、急性心肌梗死0.7%、血运重建0.3%)。快速完成负荷试验与30天主要不良心脏事件无显著关联(OR 0.92,95%CI 0.55-1.54)。作者认为在整合良好的医疗系统中,选择性门诊负荷试验是安全的,及时完成负荷试验未见获益,可能需重新评估现行指南。
要点
- 在因胸痛行肌钙蛋白检测并离院开具门诊心脏负荷试验的7,988例患者中,仅31.3%在指南推荐的3天内完成负荷试验,58.7%在4至30天完成,10.0%未完成。
- 该队列30天主要不良心脏事件发生率低:死亡0.0%、急性心肌梗死0.7%、血运重建0.3%。
- 快速完成负荷试验(3天内)与30天主要不良心脏事件无显著关联(OR 0.92,95%CI 0.55-1.54)。
- 作者认为,在整合良好的医疗系统中,选择性门诊心脏负荷试验是安全的,且3天内或30天内完成负荷试验与从未完成相比未见相关获益。
适用人群与场景
- 2015年6月至2017年6月南加州13家社区急诊中,因胸痛诊断就诊、检测肌钙蛋白、离院时开具门诊心脏负荷试验处方的成人患者。
- 研究纳入7,988例被治疗医生判定适合门诊负荷试验并离院完成诊断检查的患者。
研究设计与关键结果
- 研究类型为回顾性分析,纳入南加州13家社区急诊的7,988例成人患者,主要终点为3天内、4至30天或未完成门诊负荷试验的比例。
- 负荷试验完成率:3天内31.3%,4至30天58.7%,10.0%未完成。
- 30天主要不良心脏事件发生率:死亡0.0%、急性心肌梗死0.7%、血运重建0.3%。
- 快速完成负荷试验与30天主要不良心脏事件无显著关联(OR 0.92,95%CI 0.55-1.54)。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在整合良好的医疗系统中,选择性门诊心脏负荷试验是安全的;在该队列中,3天内或30天内完成负荷试验与从未完成相比未见相关获益。
- 作者认为,及时完成负荷试验缺乏获益,结合低客观不良事件发生率,可能需重新评估现行指南。
指南或共识出处
- 专业指南推荐急诊评估疑似急性冠脉综合征后72小时内完成心脏负荷试验(原文未指明具体指南名称)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Professional guidelines recommend 72-hour cardiac stress testing after an emergency department (ED) evaluation for possible acute coronary syndrome. There are limited data on actual compliance rates and effect on patient outcomes. Our aim is to describe rates of completion of noninvasive cardiac stress testing and associated 30-day major adverse cardiac events.
METHODS: We conducted a retrospective analysis of ED encounters from June 2015 to June 2017 across 13 community EDs within an integrated health system in Southern California. The study population included all adults with a chest pain diagnosis, troponin value, and discharge with an order for an outpatient cardiac stress test. The primary outcome was the proportion of patients who completed an outpatient stress test within the recommended 3 days, 4 to 30 days, or not at all. Secondary analysis described the 30-day incidence of major adverse cardiac events.
RESULTS: During the study period, 24,459 patients presented with a chest pain evaluation requiring troponin analysis and stress test ordering from the ED. Of these, we studied the 7,988 patients who were discharged home to complete diagnostic testing, having been deemed appropriate by the treating clinicians for an outpatient stress test. The stress test completion rate was 31.3% within 3 days and 58.7% between 4 and 30 days, and 10.0% of patients did not complete the ordered test. The 30-day rates of major adverse cardiac events were low (death 0.0%, acute myocardial infarction 0.7%, and revascularization 0.3%). Rapid receipt of stress testing was not associated with improved 30-day major adverse cardiac events (odds ratio 0.92; 95% confidence interval 0.55 to 1.54).
CONCLUSION: Less than one third of patients completed outpatient stress testing within the guideline-recommended 3 days after initial evaluation. More important, the low adverse event rates suggest that selective outpatient stress testing is safe. In this cohort of patients selected for outpatient cardiac stress testing in a well-integrated health system, there does not appear to be any associated benefit of stress testing within 3 days, nor within 30 days, compared with those who never received testing at all. The lack of benefit of obtaining timely testing, in combination with low rates of objective adverse events, may warrant reassessment of the current guidelines.
参考来源
- Natsui S, Sun BC, Shen E, et al. Evaluation of Outpatient Cardiac Stress Testing After Emergency Department Encounters for Suspected Acute Coronary Syndrome. Ann Emerg Med. 2019. PMID: 30955986. doi:10.1016/j.annemergmed.2019.01.027
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。